Astrazeneca (AZN) Acquisitions (2010 - 2025)

Astrazeneca's Acquisitions history runs 4 years deep, the most recent figure standing at -$6.0 million for Q4 2025.

• In Q4 2025, Acquisitions changed N/A year-over-year to -$6.0 million; the TTM figure through Dec 2025 stood at -$2.1 billion (up 25.98% YoY), while the FY2025 annual figure was -$66.0 million, up 97.62% from the prior year.
• Acquisitions was -$6.0 million for Q4 2025 at Astrazeneca, up from -$2.0 billion in the prior quarter.
• In the past five years, Acquisitions ranged from a high of -$6.0 million in Q4 2025 to a low of -$2.0 billion in Q2 2024.
• Historically, Acquisitions has averaged -$741.5 million across 3 years, with a median of -$457.5 million in 2023.
• Biggest YoY gain for Acquisitions was 284.13% in 2024; the steepest drop was 284.13% in 2024.
• A 3-year view of Acquisitions shows it stood at -$189.0 million in 2023, then plunged by 982.01% to -$2.0 billion in 2024, then soared by 99.71% to -$6.0 million in 2025.
• The last three Acquisitions figures came in at -$6.0 million (Q4 2025), -$2.0 billion (Q2 2024), and -$726.0 million (Q1 2024), per Business Quant data.